Chrysalis Intelligence · Product Codes · QKA

QKA · Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia

Gastroenterology, Urology · 4 clearances · 2 unique sponsors

Device class
Class II
Regulation 876.5510
Total clearances
4
2020-02-25 → 2026-06-22
Last 12 months
2
Unique sponsors
2
Definition

What is Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia

A system intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.
Medical specialty
Gastroenterology, Urology
Review panel
GU
Regulation number
876.5510
Implant
N
Life-sustain / support
N
GMP exempt
N
Third-party review
N
Trend

Clearance volume by quarter

Players

Top sponsors in this product code

Sponsor Clearances Last 12 mo Most recent
Prodeon Medical, Inc. 2 2 2026-06-22
Medi-Tate , Ltd. 2 0 2021-06-25
Reimbursement

Likely billing codes (AI-inferred · verify with billing)

Healthcare providers using this device would typically bill under these HCPCS Level II (alphanumeric) or CPT (5-digit) codes. Mapping inferred from device function by Claude Haiku; official descriptions pulled from the CMS HCPCS April 2026 quarterly file where available. Always verify with billing/coding teams before relying on these.

CodeTypeDescriptionConfidenceRationale
52275 CPT Medium Transurethral resection of prostate; may apply depending on system mechanism
52441 CPT Medium Prostate urethral stent/device placement for BPH; applicable for temporary urethral systems
Pulse

Most recent 510(k) clearances

DateK-numberSponsorDevice
2026-06-22 K261342 Prodeon Medical, Inc. Urocross Expander System (UES-2018-C1)
2026-03-12 K253525 Prodeon Medical, Inc. Urocross Expander System (Model Numbers ES2018 and ES3025)
2021-06-25 K210138 Medi-Tate , Ltd. iTind System
2020-02-25 DEN190020 Medi-Tate , Ltd. iTind System